sunitinib g.l. pharma 12,5 mg
remedica ltd. - cipru - sunitinibum - caps. - 12,5mg - inhibitori de protein-kinaza alti inhibitori de protein kinaza
sunitinib g.l. pharma 25 mg
remedica ltd. - cipru - sunitinibum - caps. - 25mg - inhibitori de protein-kinaza alti inhibitori de protein kinaza
sunitinib g.l. pharma 50 mg
remedica ltd. - cipru - sunitinibum - caps. - 50mg - inhibitori de protein-kinaza alti inhibitori de protein kinaza
tigeciclina mylan 50 mg
pharmadox healthcare, ltd - malta - tigecyclinum - pulb. pt. sol. perf. - 50mg - tetracicline tetracicline
holmevis 1 mg/1 ml
pharmathen s.a. - grecia - acid ibandronicum - conc. pt. sol. perf. - 1mg/1ml - med. ce influenteaza in structura osoasa si mineralizare bifosfonati
holmevis 2 mg/2 ml
pharmathen s.a. - grecia - acid ibandronicum - conc. pt. sol. perf. - 2mg/2ml - med. ce influenteaza in structura osoasa si mineralizare bifosfonati
holmevis 6 mg/6 ml
pharmathen s.a. - grecia - acid ibandronicum - conc. pt. sol. perf. - 6mg/6ml - med. ce influenteaza in structura osoasa si mineralizare bifosfonati
bromhexine sopharma sirop 4 mg/5 ml
sopharma plc - sirop - 4 mg/5 ml
ribavirin teva pharma b.v.
teva b.v. - ribavirină - hepatita c, cronică - antivirale pentru uz sistemic - ribavirin teva pharma b. is indicated in combination with other medicinal products for the treatment ofchronic hepatitis c (chc) in adults (see sections 4. 2, 4. 4, și 5. ribavirin teva pharma b. is indicated in combination with other medicinal products for the treatment ofchronic hepatitis c (chc) for paediatric patients (children 3 years of age and older and adolescents) notpreviously treated and without liver decompensation (see sections 4. 2, 4. 4 și 5.
axympa 180 mg
pharmadox healthcare ltd. - marea britanie - mycophenolatum - compr. gastrorez. - 180mg - imunosupresoare imunosupresoare selective